Related topics: Autumn 2008: Regulatory, industry and science insights, Health claims, Regulation
With concern about the severity of EFSA’s health claim rulings raging, industry is asking if the regime may be stifling innovation and restricting the market. Shane Starling reports.
Anke Sentko (Beneo), Jens Bleiel (DSM), Christian Artaria (Indena)09:16 |
Subscribe to podcast: |
Copyright - Unless otherwise stated all contents of this web site are © 2000/2009 - Decision News Media SAS - All Rights Reserved - For permission to reproduce any contents of this web site, please email our Syndication department: Administration & Finance - Full details for the use of materials on this site can be found in the Terms & Conditions